New research reveals that specialized gut bacteria convert bile acids into powerful healing compounds, offering hope for ...
Mirum Pharmaceuticals stock surged 25% and how LIVMARLI drives growth. Explore future prospects with Volixibat. Click here to ...
A study published in Cell Reports Medicine reveals that bowel movement frequency significantly influences physiology and long ...
Medical Xpress on MSN11d
Semisynthetic bile acid shows promise in reducing gut inflammationA study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of pro-inflammatory T helper ...
Study findings indicate therapeutic potential of microbiome-based intervention to restore bile acid balance and promote gut ...
Zacks Investment Research on MSN3d
Mirum's Heavy Dependence on Livmarli for Revenues Remains a WoeMirum Pharmaceuticals’ MIRM lead product, Livmarli (maralixibat), an orally administered ileal bile acid transporter (“IBAT”) ...
A research team has made further progress in the treatment of intestinal inflammation. A study shows that the semi-synthetic bile acid NorUDCA inhibits in the intestine the formation of ...
When mothers eat a diet high in fat and sugars, their unborn babies can develop liver stress that continues into early life.
Scientists have uncovered how a gut bacterium, Clostridium scindens, aids in healing intestinal injuries by restoring bile acid balance. Their findings could pave the way for new treatments for ...
Maternal diet, excess bile acid and liver disease - Moms who eat a high-fat, high-sugar diet during pregnancy can increase ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback